Present data show, that the dual receptor agonist tirzepatide has exceeded the glucose-lowering and body weight-lowering effects compared to the established GLP-1 RAs (66, 67, 71]
VPA is extensively metabolized by the liver via glucuronic acid conjugation, mitochondrial and cytosolic (endoplasmic reticulum) -oxidation to produce multiple metabolites, some of which may be biologically active (Fig
Copper, vitamin B 1 (thiamine), or vitamin B 6 (pyridoxine) deficiency testing Although vitamin B 6 toxicity may also result in neuropathy due to its toxic effect on the dorsal root ganglia, the mildly elevated vitamin B 6 levels often found in patients being evaluated for neuropathy are unlikely to be the primary cause of symptoms
The Dysesthesia Signal One new observation in TRIUMPH-4 was a side effect called dysesthesia, which is a sensation of tingling, tenderness, or altered touch sensitivity on the skin
The Triple-Agonist Changing Weight Loss in 2026 Retatrutide is the most powerful weight loss peptide in 2026 a triple-agonist targeting GLP-1, GIP, and glucagon
Six-to-12 months later, the patients were asked to recall if their pain had improved
